Ibrutinib-associated focal segmental glomerulosclerosis and the impact of podocin mutations in chronic lymphocytic leukemia

February 2024 | New Publication
Czogalla J et al., Kidney Int. 2024
Here, they report a case of FSGS linked to IBRU treatment in a 57-year-old male patient with CLL and provide insight into the underlying mechanism.
 
GA_KI_Czogalla_2024.jpeg

For further information visit:
KI - Ibrutinib-associated focal segmental glomerulosclerosis and the impact of podocin mutations in chronic lymphocytic leukemia

Back to News & Career

More articles in this category

Martinistraße 52
Campus Research II N25
20246 Hamburg Germany
This email address is being protected from spambots. You need JavaScript enabled to view it.

Calculate route

Categories

Services

University Medical Center Hamburg - Eppendorf

III. Department of Medicine